PRECISION BIOSCIENCES INC Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PRECISION BIOSCIENCES INC stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $30.00K, a 91.18% decline year-over-year.
- PRECISION BIOSCIENCES INC stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $9.00K, a 99.73% decline year-over-year.
- PRECISION BIOSCIENCES INC stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $38.00K, a 97.19% decline year-over-year.
- PRECISION BIOSCIENCES INC stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $340.00K, a 73.79% decline year-over-year.
- PRECISION BIOSCIENCES INC stock issued during period, value, stock options exercised for fiscal 2023 was $31.00K, a 92.09% decline from fiscal 2022.
- PRECISION BIOSCIENCES INC stock issued during period, value, stock options exercised for fiscal 2022 was $392.00K, a 94.22% decline from fiscal 2021.
- PRECISION BIOSCIENCES INC stock issued during period, value, stock options exercised for fiscal 2021 was $6.78M, a 881.62% increase from fiscal 2020.
- PRECISION BIOSCIENCES INC stock issued during period, value, stock options exercised for fiscal 2020 was $691.00K, a 45.20% decline from fiscal 2019.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2023-12-31 | $31.00K 10-K · filed 2025-03-26 | |
| 2023-03-31 | $30.00K 10-Q · filed 2024-11-04 | |
| 2022-12-31 | $392.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $9.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $38.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $340.00K 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $6.78M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $3.39M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $1.35M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $1.30M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $691.00K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $131.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $148.00K 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $212.00K 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $1.26M 10-K · filed 2021-03-18 | |
| 2019-09-30 | $61.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $272.00K 10-Q · filed 2020-11-10 | |
| 2019-03-31 | $107.00K 10-Q · filed 2020-11-10 | |
| 2018-12-31 | $171.00K 10-K · filed 2020-03-10 | |
| 2018-09-30 | $27.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $62.00K 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $20.00K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |